My interest in academic cardiology stems from my early clinical encounters under excellent cardiologists and academic supervisors during my rotations. Heart failure is of particular interest to me. It is believed that over 900,000 people in the UK have heart failure, coupled with a growing older population, advances in management of acute coronary events and relatively high rates of hospitalisation, heart failure is likely to place an increasingly significant burden on NHS services.
Fortunately there is scope to offset this impending issue through the use technology which can offer more sophisticated monitoring to potentially prevent significant events, in addition to improved management in severe disease that is refractory to traditional therapeutic options. My experience of bringing together software engineers and fellow clinicians to build useful programs for junior doctors has revealed to me the possibilities of collaboration. I believe there is a gap between existing technologies and cardiovascular medicine that could be exploited to improve treatment for diseases such as heart failure.
I have further broadened my interests by embarking on the Masters in Genomics programme which has been both intense and captivating. Genomics is likely to become extremely relevant in the next few years with the advent of personalised medicine. Multifactorial diseases such as heart failure could be partially explained and even managed by this burgeoning field of medicine.